Abiopharma

🔍 Snowling Harvey Edward (Executive)

Company: Borr Drilling Ltd (BORR)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Holds 0 shares of Common Shares (Direct)
  Date: 2026-08-24 | Code: H | shares_owned_after: 171,821.00 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-08-24 | Code: H | shares_owned_after: 52,500.00 | Footnotes: F2
• Holds 75,000 shares of Employee Stock Option to Purchase Common Shares at $6.54 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2029-08-15 | Exercise: 2025-08-15 | Footnotes: F3
• Holds 75,000 shares of Employee Stock Option to Purchase Common Shares at $6.54 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2029-08-15 | Exercise: 2026-08-15 | Footnotes: F3
• Holds 75,000 shares of Employee Stock Option to Purchase Common Shares at $6.54 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2029-08-15 | Exercise: 2027-08-15 | Footnotes: F3
• Holds 100,000 shares of Employee Stock Option to Purchase Common Shares at $6.31 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2028-11-17 | Exercise: 2025-03-01 | Footnotes: F4
• Holds 100,000 shares of Employee Stock Option to Purchase Common Shares at $6.31 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2028-11-17 | Exercise: 2026-03-01 | Footnotes: F4
• Holds 100,000 shares of Employee Stock Option to Purchase Common Shares at $6.31 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2028-11-17 | Exercise: 2027-03-01 | Footnotes: F4
• Holds 120,000 shares of Employee Stock Option to Purchase Common Shares at $3.66 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2027-09-01 | Exercise: 2024-03-01 | Footnotes: F5
• Holds 120,000 shares of Employee Stock Option to Purchase Common Shares at $4.41 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2027-09-01 | Exercise: 2025-03-01 | Footnotes: F5
• Holds 120,000 shares of Employee Stock Option to Purchase Common Shares at $5.16 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2027-09-01 | Exercise: 2026-03-01 | Footnotes: F5
• Holds 150,000 shares of Employee Stock Option to Purchase Common Shares at $1.66 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2026-12-31 | Exercise: 2023-08-12 | Footnotes: F6, F7
• Holds 150,000 shares of Employee Stock Option to Purchase Common Shares at $1.66 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2026-12-31 | Exercise: 2024-08-12 | Footnotes: F6, F7
• Holds 150,000 shares of Employee Stock Option to Purchase Common Shares at $1.66 per share (Derivative)
  Date: 2026-08-24 | Code: H | Expires: 2026-12-31 | Exercise: 2025-08-12 | Footnotes: F6, F7

Footnotes:

• F1: Includes (a) 57,274 restricted stock units (RSUs) that vest in full on September 1, 2026, (b) 57,273 RSUs that vest in full on September 1, 2027 and (c) 57,274 RSUs that vest in full on September 1, 2028, each conditional upon continuous employment with the Issuer at the date of vesting. Each RSU represents a contingent right to receive one common share
• F2: Represents (a) 17,500 restricted stock units (RSUs) that vest in full on September 1, 2027, (b) 17,500 RSUs that vest in full on September 1, 2028 and (c) 17,500 RSUs that vest in full on September 1, 2029, each conditional upon continuous employment with the Issuer at the date of vesting. Each RSU represents a contingent right to receive one common share
• F3: Grant of options on August 15, 2024 - options 1/3 vest every August 15 between 2025 and 2027 with strike price as at date of filing
• F4: Grant of options on November 17, 2023 - options 1/3 vest every March 1 between 2025 and 2027 with strike price as at date of filing
• F5: Grant of options on September 1, 2022 - options 1/3 vest every March 1 between 2024 and 2026 with staggered strike price as at date of filing
• F6: Grant of options on August 12, 2021 - options 1/3 vest every August 1 between 2023 and 2025 with strike price as at date of filing
• F7: The reported transaction involved an amendment of an outstanding option to extend the expiration date, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 12, 2021, and is 100% vested and exercisable.